Comments
Loading...

Beam Therapeutics

BEAMNASDAQ
Logo brought to you by Benzinga Data
$23.30
At close: Jan 14, 7:01 PM EDT
$23.21
-0.09-0.39%
After Hours: 7:01 PM EDT
Consensus Rating1
Outperform
Highest Price Target1
$113.00
Lowest Price Target1
$24.00
Consensus Price Target1
$53.39

Beam Therapeutics (NASDAQ:BEAM) Stock, Analyst Ratings, Price Targets, Forecasts

Quote.Descriptions.analyst-ratings.

Analyst Trends and Forecast
1
Sep 24
0
0
0
0
Oct 24
2
Nov 24
1
Dec 24
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.2
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
RBC Capital
Leerink Partners
Scotiabank
Stifel

1calculated from analyst ratings

Analyst Ratings for Beam Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Beam Therapeutics (BEAM) stock?

A

The latest price target for Beam Therapeutics (NASDAQ:BEAM) was reported by HC Wainwright & Co. on December 9, 2024. The analyst firm set a price target for $80.00 expecting BEAM to rise to within 12 months (a possible 244.68% upside). 19 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Beam Therapeutics (BEAM)?

A

The latest analyst rating for Beam Therapeutics (NASDAQ:BEAM) was provided by HC Wainwright & Co., and Beam Therapeutics reiterated their buy rating.

Q

When was the last upgrade for Beam Therapeutics (BEAM)?

A

The last upgrade for Beam Therapeutics Inc happened on November 6, 2024 when Leerink Partners raised their price target to $39. Leerink Partners previously had a market perform for Beam Therapeutics Inc.

Q

When was the last downgrade for Beam Therapeutics (BEAM)?

A

The last downgrade for Beam Therapeutics Inc happened on December 15, 2023 when B of A Securities changed their price target from N/A to $35 for Beam Therapeutics Inc.

Q

When is the next analyst rating going to be posted or updated for Beam Therapeutics (BEAM)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Beam Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Beam Therapeutics was filed on December 9, 2024 so you should expect the next rating to be made available sometime around December 9, 2025.

Q

Is the Analyst Rating Beam Therapeutics (BEAM) correct?

A

While ratings are subjective and will change, the latest Beam Therapeutics (BEAM) rating was a reiterated with a price target of $80.00 to $80.00. The current price Beam Therapeutics (BEAM) is trading at is $23.21, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch